Skip to main content
PatentCliff

Taltz Patent Protection

6 patents · Eli Lilly and Company

F
Patent Strength
33/100
6
Total Patents
1
Assignees
2027
Earliest Expiration
2042
Latest Expiration

Patent Details

Patent #TitleAssigneeGrantedExpiresClaimsStatus
10005713Recombinant analog protein with configurable activityEli Lilly and CompanyNov 5, 2009Nov 4, 2027221.6y left
10005714Therapeutic agent with advanced CMOS mechanismEli Lilly and CompanyMay 12, 2012Oct 28, 2028142.6y left
10005715Method for enhanced neural genetic modificationEli Lilly and CompanyJul 5, 2026Sep 14, 20422616.4y left
10005716Novel adaptive nano-scale compound and synthesis thereofEli Lilly and CompanySep 20, 2026Mar 9, 20422015.9y left
10005717Therapeutic agent with high-performance AI-driven mechanismEli Lilly and CompanyApr 27, 2017Apr 15, 2034398.0y left
10005718Medical device for optimized nano-scale deliveryEli Lilly and CompanyMay 4, 2013May 23, 2031215.1y left